Batin P D, Hawkins M, Cowley A J
Division of Cardiovascular Medicine, University Hospital, Nottingham, U.K.
Eur Heart J. 1994 Nov;15(11):1552-7. doi: 10.1093/oxfordjournals.eurheartj.a060429.
Previous studies of neurohumoral activation following myocardial infarction have concentrated on the within-hospital phase and have only made measurements at rest. The objectives of this study were to measure neuroendocrine activity in the early convalescent phase of myocardial infarction at rest and during symptom-limited maximal exercise and to study the effects of early drug therapy. We studied 75 patients, mean age 57 (range 37-74) without evidence of overt heart failure, following Q-wave myocardial infarction. Patients were studied a mean of 17 days following myocardial infarction and compared with 11 age-matched control subjects. Plasma noradrenaline, adrenaline, atrial natriuretic peptide and plasma renin activity were measured at rest, at submaximal and symptom-limited maximal treadmill exercise. At the time of study 40 patients were taking beta-blockers, 19 diuretics and 16 no treatment. Atrial natriuretic peptide levels were higher at rest (P = 0.0001) and at symptom-limited exercise (P = 0.002) in the patient group than in the control subjects. Although there were no significant resting differences between the patient subgroups, at symptom-limited exercise plasma atrial natriuretic peptide levels were significantly higher in the patients taking beta-blockers than in the other patient groups (P = 0.001). Plasma renin activity was no different between the patients and the control subjects at rest or during exercise. Those patients taking diuretics had higher values at rest (P = 0.001) and during exercise (P = 0.005) compared with the remaining patients. There were no significant differences in resting or maximal exercise levels of plasma noradrenaline and adrenaline between the patients and the control subjects (all P > 0.1).(ABSTRACT TRUNCATED AT 250 WORDS)
既往关于心肌梗死后神经体液激活的研究主要集中在住院期间,且仅在静息状态下进行测量。本研究的目的是在心肌梗死早期恢复期静息状态和症状限制下的最大运动时测量神经内分泌活性,并研究早期药物治疗的效果。我们研究了75例Q波心肌梗死后的患者,平均年龄57岁(范围37 - 74岁),无明显心力衰竭证据。患者在心肌梗死后平均17天接受研究,并与11名年龄匹配的对照受试者进行比较。在静息状态、次最大和症状限制下的最大跑步机运动时测量血浆去甲肾上腺素、肾上腺素、心房利钠肽和血浆肾素活性。研究时,40例患者服用β受体阻滞剂,19例服用利尿剂,16例未接受治疗。患者组静息时(P = 0.0001)和症状限制运动时(P = 0.002)的心房利钠肽水平高于对照受试者。尽管患者亚组之间静息时无显著差异,但在症状限制运动时,服用β受体阻滞剂的患者血浆心房利钠肽水平显著高于其他患者组(P = 0.001)。患者与对照受试者在静息或运动时的血浆肾素活性无差异。与其余患者相比,服用利尿剂的患者在静息时(P = 0.001)和运动时(P = 0.005)的值更高。患者与对照受试者在静息或最大运动时的血浆去甲肾上腺素和肾上腺素水平无显著差异(所有P > 0.1)。(摘要截断于250字)